Antimicrobial Agents Practice Questions

Q: Which of the following is a glycopeptide antibiotic?

Vancomycin. **Explanation:** **1. Why Vancomycin is the Correct Answer:** Vancomycin is the prototype **glycopeptide antibiotic**. Its mechanism of action involves inhibiting cell wall synthesis by binding to the **D-Ala-D-Ala** terminus of the nascent peptidoglycan pentapeptide. This prevents the cross-linking (transpeptidation) of the peptidoglycan chain, leading to bacterial cell lysis. It is primarily effective against Gram-positive bacteria. **2. Why the Other Options are Incorrect:** * **B. Penicillin:** This belongs to the **Beta-lactam** class of antibiotics. While it also inhibits cell wall synthesis, it does so by binding to Penicillin-Binding Proteins (PBPs) rather than the D-Ala-D-Ala precursor. * **C. Clindamycin:** This is a **Lincosamide** antibiotic. It acts by inhibiting protein synthesis by binding to the **50S ribosomal subunit**. * **D. Tetracycline:** This belongs to the **Tetracycline** class. It inhibits protein synthesis by binding to the **30S ribosomal subunit**, preventing the attachment of aminoacyl-tRNA. **3. NEET-PG High-Yield Clinical Pearls:** * **Drug of Choice (DOC):** Vancomycin is the DOC for **MRSA** (Methicillin-resistant *Staphylococcus aureus*) and is used orally for *Clostridioides difficile* (Pseudomembranous colitis). * **Adverse Effects:** A classic side effect is **"Red Man Syndrome,"** an infusion-related reaction caused by histamine release (prevented by slow infusion). It is also associated with **Ototoxicity** and **Nephrotoxicity**. * **Resistance:** Resistance occurs via the alteration of the binding site from D-Ala-D-Ala to **D-Ala-D-Lac** (seen in VRSA/VRE). * **Other Glycopeptides:** Teicoplanin, Telavancin, and Dalbavancin.

Q: What is the drug of choice for the treatment of Subacute Sclerosing Panencephalitis (SSPE)?

Isoprinosine. **Explanation:** **Subacute Sclerosing Panencephalitis (SSPE)** is a rare, progressive, and fatal neurodegenerative disease caused by a persistent infection with a mutated **Measles virus**. **Why Isoprinosine is the Correct Answer:** **Isoprinosine (Inosine Pranobex)** is considered the drug of choice for SSPE. It is an immunomodulatory agent that enhances T-lymphocyte function and natural killer cell activity while also inhibiting viral RNA synthesis [1]. When administered orally, it has been shown to prolong survival and, in some cases, induce clinical remission or stabilization of the disease, although it is not curative. In clinical practice, it is often used in combination with **Intrathecal/Intraventricular Interferon-alpha** [1]. **Analysis of Incorrect Options:** * **A. Abacavir:** A Nucleoside Reverse Transcriptase Inhibitor (NRTI) used specifically in the treatment of **HIV/AIDS**. It has no role in treating measles-related complications. * **C. Glatiramer:** An immunomodulator used in the management of **Multiple Sclerosis (MS)**. It acts as a myelin basic protein decoy and is not effective against viral encephalitis. * **D. Interferon:** While Interferon-alpha is used as an *adjunct* (via intrathecal route) to treat SSPE, **Isoprinosine** remains the traditional "textbook" drug of choice for initial management and systemic therapy [1]. **High-Yield Clinical Pearls for NEET-PG:** * **Pathogenesis:** SSPE occurs years after a primary measles infection (usually before age 2). * **EEG Finding:** Characterized by **periodic, high-voltage slow-wave complexes** (Radermecker complexes). * **Diagnosis:** Elevated titers of anti-measles antibodies in the **CSF** (intrathecal synthesis). * **Prognosis:** Generally fatal within 1-3 years of diagnosis; prevention via **Measles vaccination** is the most effective strategy.

Q: Which of the following antibiotics does NOT act on the cell wall?

Griseofulvin. **Explanation:** The correct answer is **Griseofulvin** because its mechanism of action is unrelated to the cell wall. **1. Why Griseofulvin is correct:** Griseofulvin is an antifungal agent that acts by binding to **tubulin**, thereby interfering with **microtubule function** and inhibiting mitosis (metaphase arrest). It does not target the fungal cell wall (chitin) or the cell membrane (ergosterol). It is uniquely fungistatic and concentrates in keratin-precursor cells, making it effective for dermatophytosis. **2. Why the other options are incorrect:** * **Ampicillin:** A Beta-lactam antibiotic that inhibits **transpeptidation** (the final step of peptidoglycan synthesis) by binding to Penicillin-Binding Proteins (PBPs). * **Bacitracin:** A polypeptide antibiotic that inhibits cell wall synthesis by interfering with the **dephosphorylation of the lipid carrier** (bactoprenol), which transports peptidoglycan subunits across the cell membrane. * **Cycloserine:** A structural analogue of D-alanine that inhibits the enzymes **L-alanine racemase** and **D-alanyl-D-alanine synthetase**, preventing the early stages of peptidoglycan formation. **3. NEET-PG High-Yield Pearls:** * **Cell Wall Synthesis Inhibitors Mnemonic:** "**F**osfomycin **C**an **B**lock **V**ery **B**ig **P**eptidoglycans" (**F**osfomycin, **C**ycloserine, **B**acitracin, **V**ancomycin, **B**eta-lactams). * **Griseofulvin Fact:** It is a potent **CYP450 inducer** and can precipitate attacks of **Acute Intermittent Porphyria**. * **Clinical Note:** Griseofulvin must be taken with a **fatty meal** to enhance absorption.

Q: Which of the following is a common complication associated with Clostridium difficile infection?

Superinfection. ### Explanation **Correct Answer: C. Superinfection** **Mechanism and Concept:** *Clostridium difficile* infection (CDI) is a classic example of a **superinfection** (or suprainfection). A superinfection occurs when the use of broad-spectrum antibiotics (e.g., Clindamycin, Fluoroquinolones, Cephalosporins) disrupts the normal protective microbial flora of the gut. This "ecological vacuum" allows the overgrowth of commensal or opportunistic pathogens that are resistant to the initial antibiotic therapy. *C. difficile* produces toxins (Toxin A and B) that lead to pseudomembranous colitis, characterized by severe diarrhea and yellow-white plaques on the colonic mucosa. **Analysis of Incorrect Options:** * **A. Tetanus:** Caused by *Clostridium tetani* via the neurotoxin tetanospasmin. It is associated with puncture wounds, not antibiotic-induced gut flora disruption. * **B. Gas Gangrene:** Caused by *Clostridium perfringens*. It is a life-threatening muscle infection (myonecrosis) typically following trauma or surgery. * **D. Food Poisoning:** While *C. perfringens* and *B. cereus* cause food poisoning, *C. difficile* is specifically associated with healthcare-associated diarrhea following antimicrobial therapy, rather than ingestion of contaminated food. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice:** Oral **Fidaxomicin** or **Vancomycin** are first-line treatments for CDI. (Note: Metronidazole is no longer the preferred first-line agent for clinical episodes). * **Most Common Culprit:** While **Clindamycin** is classically associated with CDI, **Fluoroquinolones** and **3rd Gen Cephalosporins** are currently the most frequent triggers in hospital settings. * **Diagnosis:** Confirmed by detecting *C. difficile* toxins in the stool or via PCR; colonoscopy shows characteristic **pseudomembranes**.

Q: Which of the following electrolyte imbalances is a potential adverse effect of Raltegravir?

Hyperkalemia. **Explanation:** **Raltegravir** is a first-generation **Integrase Strand Transfer Inhibitor (INSTI)** used in the management of HIV/AIDS. Its primary mechanism involves inhibiting the integrase enzyme, preventing the covalent insertion of HIV DNA into the host cell genome. **Why Hyperkalemia is Correct:** While Raltegravir is generally well-tolerated, it is known to cause metabolic and electrolyte disturbances. Clinical studies and post-marketing surveillance have identified **hyperkalemia** as a potential laboratory abnormality. The exact mechanism is not fully elucidated but is often associated with Raltegravir-induced **rhabdomyolysis** or muscle toxicity. When muscle cells are damaged, they release intracellular potassium into the bloodstream, leading to elevated serum levels. Additionally, Raltegravir can occasionally cause renal insufficiency, further impairing potassium excretion. **Analysis of Incorrect Options:** * **Hypokalemia:** Not typically associated with INSTIs. This is more commonly seen with drugs like Amphotericin B or Loop Diuretics. * **Hypocalcemia & Hypercalcemia:** Raltegravir does not significantly interfere with parathyroid hormone or Vitamin D pathways, making calcium imbalances unlikely. **High-Yield Clinical Pearls for NEET-PG:** * **Muscle Toxicity:** The most characteristic side effect of Raltegravir is an elevation in **Creatine Kinase (CK)** levels, which can progress to myopathy or rhabdomyolysis. * **Metabolism:** It is metabolized by **UGT1A1-mediated glucuronidation** (not CYP450), making it a preferred choice in patients on complex multidrug regimens. * **Other INSTIs:** Dolutegravir and Bictegravir are newer agents in this class; they are known for causing benign elevations in serum creatinine due to inhibition of the OCT2 transporter.

Q: Which drug is NOT given for malaria prophylaxis?

Artesunate. **Explanation:** The correct answer is **Artesunate**. **1. Why Artesunate is the correct answer:** Artesunate is an **Artemisinin derivative** characterized by a very short half-life (approximately 30–60 minutes). Prophylaxis requires drugs with a long half-life to maintain inhibitory concentrations in the blood over time. Because of its rapid elimination and the risk of developing resistance through monotherapy, Artesunate is strictly reserved for the **treatment** of clinical malaria (especially severe malaria via IV route) and is never used for prophylaxis. **2. Why the other options are incorrect:** * **Chloroquine:** Historically the drug of choice for prophylaxis in areas with sensitive *P. falciparum* and for *P. vivax*. It has a very long half-life (1–2 months). * **Proguanil:** Often used in combination with Atovaquone (Malarone) for causal prophylaxis. It targets the hepatic stages of the parasite. * **Doxycycline:** A standard prophylactic agent for travelers to areas with high multidrug resistance (e.g., Southeast Asia). It is a suppressive prophylactic drug. **3. NEET-PG Clinical Pearls:** * **Drug of Choice (DOC) for Severe Malaria:** Intravenous (IV) Artesunate is the gold standard. * **Prophylaxis Duration:** * *Short-term ( 6 weeks):* Mefloquine. * **Safe in Pregnancy:** Chloroquine and Proguanil are safe for prophylaxis; Mefloquine is safe in the 2nd and 3rd trimesters. * **Causal Prophylaxis:** Primaquine is the drug of choice for causal prophylaxis (acting on pre-erythrocytic stages), but it must be avoided in G6PD deficiency.

Q: Cotrimoxazole can be used for the treatment of all of the following conditions except:

Migraine. **Explanation:** **Cotrimoxazole** is a fixed-dose combination of **Sulfamethoxazole** and **Trimethoprim** in a 5:1 ratio. It works by sequential blockade of folate synthesis, making it a potent bactericidal agent. **Why Migraine is the Correct Answer:** Migraine is a neurological condition characterized by neurovascular headaches. It is not caused by a bacterial pathogen. Cotrimoxazole is an **antimicrobial agent** and has no analgesic, anti-inflammatory, or vascular properties required to treat or prevent migraine attacks. Therefore, it has no clinical indication in this condition. **Analysis of Incorrect Options:** * **Chancroid:** Caused by *Haemophilus ducreyi*. While Macrolides (Azithromycin) or Ceftriaxone are now first-line, Cotrimoxazole remains an alternative treatment option. * **Lower Urinary Tract Infections (UTIs):** Cotrimoxazole is highly effective against common uropathogens like *E. coli*. It achieves high concentrations in the urine and is a classic choice for uncomplicated UTIs. * **Typhoid (Enteric Fever):** Historically, Cotrimoxazole was a first-line drug for Typhoid. Although resistance is now common (shifting preference to Ceftriaxone or Fluoroquinolones), it is still clinically indicated for sensitive strains. **Clinical Pearls for NEET-PG:** * **Synergy:** Sulfamethoxazole inhibits *dihydropteroate synthase*, while Trimethoprim inhibits *dihydrofolate reductase*. * **DOC (Drug of Choice):** Cotrimoxazole is the drug of choice for ***Pneumocystis jirovecii* pneumonia (PCP)**, *Nocardiosis*, and *Burkholderia cepacia* infections. * **Adverse Effects:** Watch for **Stevens-Johnson Syndrome (SJS)** and hemolysis in patients with **G6PD deficiency**. * **Ratio:** The 5:1 dose ratio results in a 20:1 plasma concentration ratio, which is optimal for synergistic effects.

Q: What is the mechanism of action of aminoglycosides?

Inhibition of protein synthesis. **Explanation:** Aminoglycosides (e.g., Gentamicin, Amikacin, Streptomycin) are potent bactericidal antibiotics that act by **inhibiting protein synthesis**. They bind irreversibly to the **30S ribosomal subunit**, leading to three primary effects: 1. Interference with the initiation complex of peptide formation. 2. Induction of mRNA misreading, resulting in the synthesis of non-functional or toxic proteins. 3. Breakup of polysomes into non-functional monosomes. **Analysis of Options:** * **Option A (Correct):** Aminoglycosides specifically target the 30S subunit to halt translation. * **Option B (Incorrect):** This is the mechanism of Polymyxins (Daptomycin/Colistin) and certain antifungals (Amphotericin B), which disrupt the integrity of the bacterial or fungal membrane. * **Option C (Incorrect):** Protein coagulation is a non-specific mechanism characteristic of antiseptics and disinfectants (like phenols or alcohols), not selective antibiotics. * **Option D (Incorrect):** This describes the mechanism of Beta-lactams (Penicillins, Cephalosporins) and Glycopeptides (Vancomycin), which target peptidoglycan synthesis. **High-Yield Clinical Pearls for NEET-PG:** * **Bactericidal Exception:** Unlike most protein synthesis inhibitors (which are bacteriostatic), aminoglycosides are **bactericidal**. * **Oxygen Dependency:** Their transport into bacteria is oxygen-dependent; therefore, they are **ineffective against anaerobes**. * **Post-Antibiotic Effect (PAE):** They exhibit a significant PAE, allowing for once-daily dosing despite a short half-life. * **Toxicity:** Monitor for **Ototoxicity** (vestibular/cochlear damage) and **Nephrotoxicity** (Acute Tubular Necrosis). * **Synergy:** They are often combined with cell wall inhibitors (like Penicillins) to facilitate entry into the cell, especially in treating Enterococcal endocarditis.

Q: All of the following are antifungal drugs that inhibit ergosterol biosynthesis EXCEPT?

Amphotericin B. ### Explanation The cell membrane of fungi contains **ergosterol**, a vital sterol that maintains membrane integrity. Antifungal agents target this pathway in two distinct ways: by inhibiting its **synthesis** or by binding to the **existing sterol** to cause membrane damage. **1. Why Amphotericin B is the correct answer:** Amphotericin B belongs to the **Polyene** class. Unlike Azoles, it does **not** inhibit the biosynthesis of ergosterol. Instead, it binds directly to the pre-formed ergosterol molecules already present in the fungal cell membrane [3]. This binding creates transmembrane pores (ion channels), leading to the leakage of intracellular contents (like $K^+$) and subsequent cell death [2]. **2. Why the other options are incorrect:** * **Ketoconazole & Fluconazole:** These are **Azoles**. They work by inhibiting the enzyme **14-$\alpha$-demethylase** (a cytochrome P450 enzyme) [1]. This enzyme is responsible for converting lanosterol into ergosterol. By blocking this step, they inhibit the **biosynthesis** of ergosterol, leading to the accumulation of toxic precursor sterols and membrane dysfunction [1]. **3. High-Yield Clinical Pearls for NEET-PG:** * **Mechanism of Resistance:** Resistance to Amphotericin B occurs via a decrease in the ergosterol content of the fungal membrane. * **Side Effects of Amphotericin B:** Known for "infusion-related reactions" (fever, chills) and **nephrotoxicity** (causes distal renal tubular acidosis and hypokalemia) [3], [5]. Liposomal formulations are used to reduce toxicity [5]. * **Terbinafine:** Another inhibitor of ergosterol biosynthesis, but it acts earlier in the pathway by inhibiting **Squalene epoxidase**. * **Echinocandins (e.g., Caspofungin):** These do NOT target ergosterol; they inhibit the synthesis of **$\beta$-(1,3)-D-glucan**, a component of the fungal **cell wall** [4].

Question 1

Which of the following is a glycopeptide antibiotic?

Accepted Answer

Vancomycin

Answer

Penicillin

Answer

Clindamycin

Answer

Tetracycline

Question 2

What is the drug of choice for the treatment of Subacute Sclerosing Panencephalitis (SSPE)?

Accepted Answer

Isoprinosine

Answer

Abacavir

Answer

Glatiramer

Answer

Interferon

Question 3

Which of the following antibiotics does NOT act on the cell wall?

Accepted Answer

Griseofulvin

Answer

Ampicillin

Answer

Bacitracin

Answer

Cycloserine

Question 4

A patient with AIDS who is pregnant is not administered a particular antiretroviral drug orally due to its composition of propylene glycol. This drug is known to cause hyper-pigmentation on the palms of the hands and soles of the feet. Which drug is it?

Accepted Answer

Emtricitabine

Answer

Amprenavir

Answer

Eirenz

Answer

Zalcitabine

Question 5

Which of the following is a common complication associated with Clostridium difficile infection?

Accepted Answer

Superinfection

Answer

Tetanus

Answer

Gas gangrene

Answer

Food poisoning

Question 6

Which of the following electrolyte imbalances is a potential adverse effect of Raltegravir?

Accepted Answer

Hyperkalemia

Answer

Hypokalemia

Answer

Hypocalcemia

Answer

Hypercalcemia

Question 7

Which drug is NOT given for malaria prophylaxis?

Accepted Answer

Artesunate

Answer

Chloroquine

Answer

Proguanil

Answer

Doxycycline

Question 8

Cotrimoxazole can be used for the treatment of all of the following conditions except:

Accepted Answer

Migraine

Answer

Chancroid

Answer

Lower urinary tract infections

Answer

Typhoid

Question 9

What is the mechanism of action of aminoglycosides?

Accepted Answer

Inhibition of protein synthesis

Answer

Damage to cell membrane

Answer

Coagulation of proteins

Answer

Inhibition of cell wall synthesis

Question 10

All of the following are antifungal drugs that inhibit ergosterol biosynthesis EXCEPT?

Accepted Answer

Amphotericin B

Answer

Ketoconazole

Answer

Fluconazole

Answer

None of these

Antimicrobial Agents — MCQs

Antimicrobial Agents — MCQs

On this page

Practice by Chapter

Want unlimited practice?